Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · IEX Real-Time Price · USD
0.0599
+0.0029 (5.09%)
Mar 28, 2024, 11:59 AM EDT - Market open

Sunshine Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2007
Net Income
-26.74-12.44-2.78-1.66-2.16-1.04-3.5-1.65-1.93-2.49
Upgrade
Depreciation & Amortization
0.030.010.010.010.050.010.06000
Upgrade
Share-Based Compensation
00.920.050.260.680.430.70.121.260
Upgrade
Other Operating Activities
21.479.682.060.890.920.062.420.660.141.93
Upgrade
Operating Cash Flow
-5.25-1.83-0.66-0.5-0.51-0.54-0.31-0.87-0.54-0.56
Upgrade
Capital Expenditures
-0.160-0-0-0.02-0-0-000
Upgrade
Acquisitions
-14.3500-0.010-0.080000
Upgrade
Other Investing Activities
-0.11-------0.62--
Upgrade
Investing Cash Flow
-14.620-0-0.02-0.01-0.08-0-0.6200
Upgrade
Share Issuance / Repurchase
30.3700000.060.10.240.150
Upgrade
Debt Issued / Paid
-42.841.570.440.490.610.221.150.430.46
Upgrade
Other Financing Activities
13.090.060.04-0.04--0.010.06-
Upgrade
Financing Cash Flow
39.472.91.610.440.530.670.321.40.650.46
Upgrade
Exchange Rate Effect
0.18-0.02-0-0.010.010.01-0000
Upgrade
Net Cash Flow
19.61.080.95-0.0700.040.01-0.090.11-0.1
Upgrade
Free Cash Flow
-5.41-1.83-0.66-0.5-0.53-0.55-0.32-0.87-0.54-0.56
Upgrade
Free Cash Flow Margin
-124.47%-800.75%-922.13%-2351.49%----51079.45%--
Upgrade
Free Cash Flow Per Share
-0.36-0.70-0.65-9.09-34.90-50.17-59.80-570.78-651.54-815.08
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).